SCHEMBL24784362

SCHEMBL24784362

COc1c(C)c(C(O)CCCCCCCO)c(OC)c(OC)c1OC

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
LMNA P02545 1/20 0.32
PGR P06401 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
MAOA P21397 1/20 0.32
TBXA2R P21731 1/20 0.32
MAPK1 P28482 1/20 0.32
AVPR2 P30518 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTR2B P41595 1/20 0.32
HTT P42858 1/20 0.32
PDE3A Q14432 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SLC29A1 Q99808 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TOP1 P11387 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24783640 1.00 ALOX5 (0.38) ALOX5LMNAPGRCYP3A4CYP2D6
SCHEMBL3456115 0.81 USP2 (0.38) CYP3A4MAPTMAPK1
SCHEMBL9308823 0.77 TBXA2R (0.39) ALOX5CYP2C9TBXA2R
SCHEMBL14666117 0.76 USP2 (0.39) CYP3A4CYP2D6MAPTCYP2C9MAPK1
SCHEMBL9309778 0.75 TBXA2R (0.38) CYP2C9TBXA2R
SCHEMBL24784363 0.71 LMNA (0.42) ALOX5LMNAPGRCYP3A4CYP2D6
SCHEMBL24783641 0.71 LMNA (0.42) ALOX5LMNAPGRCYP3A4CYP2D6
SCHEMBL11098325 0.68 LMNA (0.40) ALOX5LMNAPGRCYP3A4CYP2D6
SCHEMBL22172495 0.67 LMNA (0.42) ALOX5LMNAPGRCYP3A4CYP2D6
SCHEMBL1242706 0.66 TNKS2 (0.35) ALOX5LMNAPGRCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300987-A1 TRAP1 INHIBITOR AND USE THEREOF UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2024-09-12 US disclosed
EP-4357351-A1 TRAP1 INHIBITOR AND USE THEREOF Smartin Bio Inc. (KR) 2024-04-24 EP disclosed
CN-117769559-A TRAP1 inhibitors and uses thereof 斯玛特恩生物公司 2024-03-26 CN disclosed
WO-2022265178-A1 TRAP1 INHIBITOR AND USE THEREOF 주식회사 스마틴바이오 2022-12-22 WO disclosed
WO-2022265178-A1 TRAP1 INHIBITOR AND USE THEREOF 주식회사 스마틴바이오 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300987-A1 TRAP1 INHIBITOR AND USE THEREOF TRAP1, PPP1R7, PPP1R15A ALOX5 4762/4885LMNA 3772/4885PGR 4008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.